These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7646275

  • 1. [Natural history of hypertrophic obstructive cardiomyopathy in young patients: apropos of 40 cases].
    Azzano O, Bozio A, Sassolas F, Di Filippo S, Agé C, André M, Jocteur-Monrozier D, Normand J.
    Arch Mal Coeur Vaiss; 1995 May; 88(5):667-72. PubMed ID: 7646275
    [Abstract] [Full Text] [Related]

  • 2. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.
    Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1529-36. PubMed ID: 7594081
    [Abstract] [Full Text] [Related]

  • 3. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar 15; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 4. Myocardial bridging in children with hypertrophic cardiomyopathy--a risk factor for sudden death.
    Yetman AT, McCrindle BW, MacDonald C, Freedom RM, Gow R.
    N Engl J Med; 1998 Oct 22; 339(17):1201-9. PubMed ID: 9780340
    [Abstract] [Full Text] [Related]

  • 5. [Hypertrophic obstructive cardiomyopathy: spontaneous course in comparison to long-term therapy with propranolol and verapamil].
    Haberer T, Hess OM, Jenni R, Krayenbühl HP.
    Z Kardiol; 1983 Sep 22; 72(9):487-93. PubMed ID: 6415946
    [Abstract] [Full Text] [Related]

  • 6. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years.
    Schulte HD, Bircks WH, Loesse B, Godehardt EA, Schwartzkopff B.
    J Thorac Cardiovasc Surg; 1993 Oct 22; 106(4):709-17. PubMed ID: 8412267
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prognostic factors after sustained ventricular fibrillation or tachycardia. A multivariate study apropos of 160 cases].
    Fleurant E, Lacroix D, Klug D, Warembourg H, Kacet S, Lekieffre J.
    Arch Mal Coeur Vaiss; 1996 Apr 22; 89(4):435-44. PubMed ID: 8763003
    [Abstract] [Full Text] [Related]

  • 11. Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil.
    Arteaga E, Ianni BM, Fernandes F, Mady C.
    Am Heart J; 2005 Jun 22; 149(6):1099-105. PubMed ID: 15976794
    [Abstract] [Full Text] [Related]

  • 12. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 22; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 13. [Hypertrophic cardiomyopathy: spontaneous course].
    Seiler C.
    Schweiz Med Wochenschr; 1995 Oct 14; 125(41):1931-9. PubMed ID: 7481651
    [Abstract] [Full Text] [Related]

  • 14. [Obstructive hypertrophic cardiomyopathy: medical or surgical treatment?].
    Azzano O, Garé JP, de Gevigney G, Milon H, Mikaeloff P, Delahaye JP.
    Arch Mal Coeur Vaiss; 1993 Jul 14; 86(7):987-93. PubMed ID: 8291946
    [Abstract] [Full Text] [Related]

  • 15. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA, Rosenberg MA, Fifer MA, Palacios IF, Lowry PA, Ruskin JN, Sanborn DM, Picard MH, Vlahakes GJ, Mela T, Das S.
    Am J Cardiol; 2009 Jul 01; 104(1):128-32. PubMed ID: 19576333
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
    Pokorski RJ.
    J Insur Med; 2002 Jul 01; 34(1):43-60. PubMed ID: 15303593
    [Abstract] [Full Text] [Related]

  • 18. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy.
    Zecchin M, Di Lenarda A, Proclemer A, Faganello G, Facchin D, Petz E, Sinagra G.
    Europace; 2004 Sep 01; 6(5):400-6. PubMed ID: 15294264
    [Abstract] [Full Text] [Related]

  • 19. [Clinical course of hypertrophic cardiomyopathy in a non selected population. The Experience of the Italian Multicenter Cardiomyopathy Study].
    Cecchi F, Olivotto I, Lazzeroni E, Chiriatti G, Sachero A, Beretta L, Giagnoni E, Renosto G, Montereggi A, Baldassarre S, Castelli G, Ciaccheri M.
    G Ital Cardiol; 1997 Nov 01; 27(11):1133-43. PubMed ID: 9463057
    [Abstract] [Full Text] [Related]

  • 20. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M, Schlaepfer J, Kappenberger L, Fromer M.
    Schweiz Med Wochenschr; 1997 Apr 12; 127(15):623-30. PubMed ID: 9198888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.